JUN 29, 2018 5:36 AM PDT

Amazon Buys Online Pharmacy PillPack, Drugstore Stocks Tumble

WRITTEN BY: Julia Travers

On June 28, 2018, the web retail giant Amazon announced it was acquiring an online pharmacy company called PillPack. Amazon’s entry into the prescription and pharmacy field caused a quick drop in drugstore stocks on the same day, including Rite Aid, Walgreens Boots Alliance and CVS Health, which fell 11.1, 9.9 and 6.1 percent, respectively. Patients in the U.S. order billions of prescriptions that cost hundreds of billions annually, and the business of filling them is understandably a very competitive industry.

Jeff Wilke, Amazon CEO of Worldwide Consumer, said the following in a statement:

PillPack’s visionary team has a combination of deep pharmacy experience and a focus on technology. PillPack is meaningfully improving its customers’ lives, and we want to help them continue making it easy for people to save time, simplify their lives and feel healthier. We’re excited to see what we can do together on behalf of customers over time.

Image of pills, credit: public domain

PillPack’s online services include handling patient data and measuring, packaging and delivering the correct doses of medicine. It is licensed to do so in 49 states, its site states. PillPack uses an operating system called PharmacyOS to administer patient prescriptions, including managing potential medication interactions.

PillPack sorts a user’s medicine into prepackaged doses that can be labeled by day and time. They coordinate with doctors to auto-refill drugs for patients. The company states that about 50 percent of Americans don’t take their meds as described and that it aims to remedy the situation.

For the time being, PillPack co-founder and CEO TJ Parker is expected to stay on board after the acquisition.

“PillPack makes it simple for any customer to take the right medication at the right time, and feel healthier,” he said in a statement.

Walgreens Boots Alliance CEO Stefano Pessina recognized the import of the deal between Amazon and PillPack but expressed confidence in her stores, saying “the pharmacy world is much more complex than the delivery of a certain [pills or] packages,” according to CNBC.

CVS Health also communicated comfort in the import and necessity of their services, adding that they have not seen a major move toward patients preferring home delivery for their prescriptions. In a comment to CNBC, a company rep said:

We already have the capabilities that PillPack is offering and we have scale in the business … And for those patients that do desire to transition [to online services], we offer the option to ship their prescriptions to their home from our pharmacies or obtain the prescriptions through our Caremark mail facilities.

PillPack, which was valued at about $361 million after a 2016 funding round, was previously considering a deal with Walmart, according to Tech Crunch. The company is based out of New Hampshire and originated out of a startup accelerator called Techstars in Boston in 2013.

 

Sources:

Tech Crunch

CNBC

PillPack

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JUL 02, 2020
Chemistry & Physics
Carbon Nanolattices: Lighter Than (Atomic) Feathers, Tougher Than Diamonds
JUL 02, 2020
Carbon Nanolattices: Lighter Than (Atomic) Feathers, Tougher Than Diamonds
Carbon is known for its plentiful allotropes, such as the naturally existing graphite and diamond, as well as synthetic ...
SEP 03, 2020
Chemistry & Physics
Nuclear Pioneers Joined Force to Fast-Track Clean Energy Tech
SEP 03, 2020
Nuclear Pioneers Joined Force to Fast-Track Clean Energy Tech
Last week, TerraPower, a Bill Gates-backed nuclear startup, announced its latest project - a collaboration with GE Hitac ...
OCT 09, 2020
Technology
Deep Learning Advances Drug Design
OCT 09, 2020
Deep Learning Advances Drug Design
Computational data is advancing all areas of medicine and pharmaceutical drug development is certainly no exception. &nb ...
NOV 17, 2020
Cardiology
Validating Blood Pressure Functionality in a New Smartwatch
NOV 17, 2020
Validating Blood Pressure Functionality in a New Smartwatch
One of the most exciting advancements in our time is wearable technology. While most see it as a cool piece of tech on y ...
NOV 18, 2020
Technology
Using Machine Learning to Build Chemical Libraries
NOV 18, 2020
Using Machine Learning to Build Chemical Libraries
Using machine learning in drug discovery is no longer a novel procedure and has been well documented in recent literatur ...
NOV 29, 2020
Cell & Molecular Biology
Engineering 'Smart' Cells to Kill Cancer
NOV 29, 2020
Engineering 'Smart' Cells to Kill Cancer
Cancer researchers have long been searching for a way to target cancer cells while ignoring healthy cells. A team of sci ...
Loading Comments...